Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma.
Cockett
A T
AT
Department of Urology, University of Rochester, New York 14642.
Merguerian
P A
PA
di Sant'Agnese
P A
PA
Wheeless
L L
LL
D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine; D007376:Interleukin-2